Publikationen
Wichtige Publikationen seit dem Jahr 2000
Berücksichtigt werden wissenschaftliche Veröffentlichungen in Zeitschriften, Sammelbänden und Monographien sowie Patente unter Beteiligung von Mitarbeitern des Diabetes Zentrums.
Schott M, Feldkamp J, Schattenberg D, Krueger T, Dotzenrath C, Seissler J, Scherbaum WA. (2000). Induction of cellular immunity in a parathyroid carcinoma treated with tumor lysate-pulsed dendritic cells. Eur J Endocrinol 142, 300-306.
Seissler J, Nguyen TBT, Aust G, Steinbrenner H, Scherbaum WA. (2000). Regulation of the diabetes-associated autoantigen IA-2 in INS-1 pancreatic ß-cells. Diabetes 49, 1137-1141.
Weiss PAM, Scholz HS, Haas J, Tamussino KF, Seissler J, Borkenstein MH. (2000). Long-term follow-up of infants of mothers with type 1 diabetes. Evidence for heriditary and nonheriditary transmission of diabetes and precursors. Diabetes Care 23, 905-911.
Ohly P, Dohle C, Abel J, Seissler J, Gleichmann H. (2000). Zinc sulfate induces metallothionein in pancreatic islets of mice and protects against diabetes induced by multiple low doses of streptozotocin. Diabetologia 43, 1020-1030.
Lohmann T, List C, Lamesch P, Kohlhaw K, Wenzke M, Schwarz C, Richter O, Hauss J, Seissler J. (2000). Diabetes mellitus and islet cell specific autoimmunity as adverse effects of immunosuppressive therapy by FK506/Tacrolimus. Exp Clin Endocrinol Diabetes 108, 347-352.
Hartmann B, Seissler J, Braunstein S, Tschöpe D. (2000). Maskierung eines autoimmunen polyendokrinen Syndroms durch Folgeerkrankungen des Diabetes mellitus. Med Klinik 95, 632-637.
Scherbaum WA, Seissler J. (2000) Prädiktion und Prävention des Typ 1-Diabetes mellitus. J.R. Kalden, H. Klinger, D. Welzel, Eds. In: Die Innere Medizin an der Schwelle des neuen Jahrhunderts. Schattauer Verlag Stuttgart; 44-54.
Seissler J, Scherbaum WA. (2000) Das Stiff-Man-Syndrom aus internistischer und immunologischer Sicht. Der Internist 41, 460-466.
Seissler J, Schott M, Morgenthaler NG, Scherbaum WA. (2000). Mapping of novel autoreactive epitopes of the diabetes-associated autoantigen IA-2. Clin Exp Immunol 122, 157-163.
Schattenberg D, Schott M, Reindl G, Krueger T, Feldkamp J, Tschoepe D, Scherbaum WA, Seissler J. (2000). Response of human monocyte-derived dendritic cells to immunostimulatory DNA. Eur J Immunol 30, 2824-2831.
Steinbrenner H, Lohmann T, Ostendorf B, Scherbaum WA, Seissler J. (2000). Autoantibodies to ICA12 (SOX-13) are not specific for type 1 diabetes. Diabetologia 43, 1381-1384.
Schott M, Feldkamp J, Bathan C, Scherbaum WA, Seissler J. (2000). Detecting TSH-receptor antibodies with the recombinant TBII assay: technical and clinical evaluation. Horm Metab Res 32, 429-435.
Seissler J, Wagner S, Schott M, Feldkamp J, Lettmann M, Scherbaum WA, Morgenthaler NG. (2000) Detection of autoantibodies to the full length human Na+/I- symporter expressed by in vitro transcription/translation: evidence for low frequency in patients with autoimmune thyroid disease. J Clin Endocrinol Metab 85, 4630-4634.
Rau H, Braun J, Donner H, Seissler J, Siegmund T, Usadel KH, Badenhoop K. (2001). The codon 17 polymorphism of the CTLA4 gene in type 2 diabetes mellitus. J Clin Endorinol Metab 86, 653-655.
Rickert M, Seissler J, Dangel W, Lorenz H, Richter W. (2001). GAD65-IAic fusion proteins for combined detection of GAD65 and IA2 autoantibodies in type 1 diabetes. Clin Chem 47, 926-934.
Meinck HM, Maile S, Morgenthaler NG, Seissler J, Faber L, Butler M, Solimena M, DeCamilli P, Scherbaum WA. (2001). Antibodies against glutamic acid decarboxylase (GAD): prevalence in neurological diseases. J Neurol Neurosurg Psychiatrie, 71, 100-103.
Seissler J, Wohlrab U, Wuensche C, Scherbaum WA, Boehm BO. (2001). Autoantibodies from patients with coeliac disease recognize distinct functional domains of the autoantigen tissue transglutaminase. Clin Exp Immunol 125, 216-221.
Schott M, Feldkamp J, Lettmann M, Simon D, Scherbaum WA, Seissler J. (2001). Dendritic cell immunotherapy in a neuroendocrine pancreas carcinoma. Clin Endocrinol 55, 271-277.
Feldkamp J, Pascher E, Schott M, Goretzki P, Seissler J, Scherbaum WA. (2001). Soluble fas is increased in hyperthyroidism independent of the underlying thyroid disease. J Clin Endocrinol Metab 86, 4250-4253.
Schott M*, Seissler J*, Lettmann M, Fouxon V, Scherbaum WA, Feldkamp J. (2001). Immunotherapy for medullary thyroid carcinoma by dendritic cell vaccination. J Clin Endocrinol Metab 86, 4965-4969.
Lohmann T, Kellner K, Verlohren HJ, Krug J, Steindorf J, Scherbaum WA, Seissler J. (2001). Titer and combination of ICA and autoantibodies against glutamic acid decarboxylase discriminate two distinct types of latent autoimmune diabetes in adults. Diabetologia 44, 1005-1010.
Seissler J, Hatziagelaki E, Scherbaum WA. (2001) Modern concepts in the prediction of type 1 diabetes. Exp Clin Endocrinol Diabetes 109 Suppl. 2, 304-316.
Seissler J. (2001) Pharmaka mit Wirkung auf das Immunsystem. E. Oberdisse, E. Hackenthal, K. Kuschinsky, Eds. In: Pharmakologie und Toxikologie. Springer Verlag Berlin-Heidelberg-New York; 744-751.
Seissler J, Eikamp K, Schott M, Scherbaum WA. (2002). IA-2 autoantibodies restricted to the IgG4 subclass are associated with protection from type 1 diabetes. Horm Metab Res 34, 186-191.
Spiekerkoetter U, Seissler J, Wendel U. (2002). General screening for coeliac disease is advisable in children with type 1 diabetes. Horm Metab Res 34, 192-195.
Pani MA, Seidl C, Bieda K, Seissler J, Krause M, Seifried E, Usadel KH, Badenhoop K. (2002). Preliminary evidence that an endogenous retroviral long terminal repeat (LTR13) At the HLA-DQB1 gene locus confers susceptibility to Addison´s disease. Clin Endocrinol 56, 773-777.
Steinbrenner H, Nguyen TBT, Wohlrab U, Scherbaum WA, Seissler J. (2002). Proinflammatory cytokines downregulate gene expression of the diabetes-associated autoantigen IA-2. Endocrinology 143, 3839-3845.
Löbner K, Steinbrenner H, Roberts GA, Ling Z, Huang GC, Piquer S, Pipeleers DG, Seissler J, Christie MR. (2002). Different regulated expression of the tyrosine phosphatase-like protein IA-2 and phogrin by glucose and insulin in pancreatic islets: relationship to the development of insulin secretory responses in early life. Diabetes 51, 2982-2988.
Pani MA, Seissler J, Usadel KH, Badenhoop K. (2002). Vitamin D receptor genotype is associated with Addison´s disease. Eur J Endocrinol 147, 635-640.
Schott M, Feldkamp J, Klucken M, Kobbe G, Scherbaum WA, Seissler J. (2002). The polypeptide hormone calcitonin can be used to induce antitumor immunitry in medullary carcinoma. Cancer Immunol Immunotherapy 51: 663-668.
Wagner S, Aust G, Schott M, Scherbaum WA, Feldkamp J, Seissler J. (2002). Regulation of sodium-iodide-symporter gene expression in human thyrocytes measured by real-time polymerase chain reaction. Exp Clin Endocrinol Diabetes 110: 398-402.
Scherbaum WA, Seissler J. (2002) Immunoendocrinopathy syndromes. J.A.H. Waas, S.M. Shalet Eds. In: Oxford Textbook of Endocrinology and Diabetes. Oxford University Press New York; 1472-1478.
Schott M, Seissler J, Scherbaum WA, Feldkamp. (2002) Tumorimmuntherapie mit dendritischen Zellen beim metastasierten medullären Schilddrüsenkarzinom. M. Schott, W.A. Scherbaum, J. Feldkamp, Eds. In: Medulläres Schilddrüsenkarzinom. DeGruyter Verlag Berlin-New York; 117-131.
Seissler J, Scherbaum WA. (2002) Are we ready to predict and prevent endocrine/organ-specific autoimmune diseases? Springer Semin Immunopathol 24, 273-295.
Scherbaum WA, Hauner H, Toeller M, Koschnisky T, Seissler J, Tschöpe D, Ziegler D, Baehring T, Martin S. (2003) Futurologie. Mehnert H, Standl E, Usadel KH, Häring HU, Eds. In: Diabetologie in Klinik und Praxis. Georg Thieme Verlag Stuttgart-New York; 793-800.
Schott M, Seissler J. (2003) Dendritic cell vaccination: new hope for the treatment of metastasized endocrine malignancies. Trends Endocrinol Metab 14, 156-162.
Lichtenauer UD, Seissler J, Scherbaum WA. (2003) Die diabetischen Folgeerkrankungen. Mikro- und makroangiopathische Organschäden. Der Internist 44, 840-852.
Schiemann U, Dieterle C, Gotzberger M, Landgraf R, Heldwein W. (2003) Improved ultrasound examination of pancreas grafts in type 1 (insulin-dependent) diabetic patients using tissue harmonic imaging.Transplant Proc 35:3081-3084
Hanifi-Moghaddam P, Schloot NC, Kappler S, Seissler J, Kolb H. (2003). An association of autoantibody status and serum cytokine levels in type 1 diabetes. Diabetes 52:1137-1142.
Krueger T, Wohlrab U, Klucken M, Schott M, Seissler J. (2003). Autoantigen-specific protection of nonobese diabetic mice from cyclophosphamide-accelerated diabetes by vaccination with dendritic cells. Diabetologia 46, 1357-1365.
Dieterle CD, Schmauss S, Veitenhansl M, Gutt B, Illner WD, Land W, Landgraf R. (2004) Glucose metabolism after pancreas transplantation: cyclosporine versus tacrolimus. Transplantation 77:1561-1565.
Dieterle CP, Conzelmann M, Linnemann U, Berger MR..(2004) Detection of isolated tumor cells by polymerase chain reaction-restriction fragment length polymorphism for K-ras mutations in tissue samples of 199 colorectal cancer patients. Clin Cancer Res 10:641-650
Schott M, Morgenthaler NG, Fritzen R, Feldkamp J, Scherbaum WA, Seissler J. (2004). Levels of autoantibodies against human TSH receptor predict relapse of hyperthyroidism in Graves´ disease. Horm Met Res 36, 92-96.
Schott M, Scherbaum WA, Seissler J. (2004) Dendritic cell-based immunotherapy for endocrine malignancies. Curr Drug Targets Immune Endocr Metabol Disord 4, 59-66.
Ramos-Lopez E, Zwermann O, Meyer G, Reincke M, Seissler J, Herwig J, Usadel KH, Badenhoop K. (2004). A promotor polymorphism of the CYP28B1 gene is associated with Addison´s disease, Hashimoto´s thyroiditis, Graves´disease and type 1 diabetes mellitus in Germans. Europ J Endocrinol 151, 1993-197.
Schott M, Seissler J, Scherbaum WA. (2004). IGF-1, IGFBP-3, and cancer risk. Lancet 364, 325.
Dieterle CD, Hierl FX, Gutt B, Arbogast H, Meier GR, Veitenhansl M, Hoffmann JN, Landgraf R. (2005) Insulin and islet autoantibodies after pancreas transplantation. Transpl Int 18:1361-1365.
Malaise J, Arbogast H, Illner WD, Tarabichi A, Dieterle C, Landgraf R, Land W, Van Ophem D, Squifflet JP; EUROSPK Study Group. (2005) Simultaneous pancreas-kidney transplantation: analysis of rejection. Transplant Proc 37:2856-2858.
Arbogast H, Malaise J, Illner WD, Tarabichi A, Dieterle C, Landgraf R, Land W; Euro-SPK Study Group. (2005) Rejection after simultaneous pancreas-kidney transplantation. Nephrol Dial Transplant 20 Suppl 2:ii11-17.
Gutt B, Bidlingmaier M, Kretschmar K, Dieterle C, Steffin B, Schopohl J. (2005) Four-year follow-up of acromegalic patients treated with the new long-acting formulation of Lanreotide Lanreotide Autogel).Exp Clin Endocrinol Diabetes 113:139-144.
Schilling J, Spiekerkoetter U, Wohlrab U, Wendel U, Seissler J. (2005). Immunoglobulin isotype profile of tissue transglutaminase autoantibodies is correlated with the clinical presentation of coeliac disease. Scand J Immunol 61, 207-212.
Schott M, Minich WB, Willenberg HS, Papewalis C, Seissler J, Feldkamp J, Bergmann A, Scherbaum WA, Morgenthaler NG. (2005) Relevance of TSH receptor stimulating and blocking autoantibody measurement for the prediction of relapse in Graves' disease.Horm Metab Res 37, 741-744.
Steffin B, Gutt B, Bidlingmaier M, Dieterle C, Oltmann F, Schopohl J. (2006) Effects of the long-acting somatostatin analogue Lanreotide Autogel on glucose tolerance and insulin resistance in acromegaly.Eur J Endocrinol 155:73-78.
Fertmann JM, Wimmer CD, Arbogast HP, Illner WD, Tarabichi A, Calasan I, Dieterle C, Land W, Jauch KW, Hoffmann JN. (2006) Single-shot antithrombin in human pancreas-kidney transplantation: reduction of reperfusion pancreatitis and prevention of graft thrombosis. Transpl Int 19:458-465.
Dieterle C. (2006) (Auto)immunological aspects of type 1 diabetes mellitus. MMW Fortschr Med 148:36-39.
Dieterle C, Landgraf R. (2006) Comorbidities and complications of adiposis. Internist 2006 47:141-149.
Herder C, Müller-Scholze S, Rating P, Koenig W, Thorand B, Haastert B, Holle R, Illig T, Rathmann W, Seissler J, Wichmann HE, Kolb H. (2006) Systemic monocyte chemoattractant protein-1 concentrations are independent of Type 2 diabetes mellitus or parameters of obesity: Results from the KORA Survey 2000, Eur J Endocrinol, 154, 311-317.
Hanifi-Moghaddam P, Kappler S, Seissler J, Müller-Scholze S, Martin S, Roep BO, Strassburger K, Kolb H, Schloot NC. (2006) Altered chemokine levels in individuals at risk of Type 1 diabetes mellitus. Diabetic Med 23, 156-163.
Seissler J, Scherbaum WA. (2006) Autoimmune diagnostics in diabetes mellitus. Clin Chem Lab Med 44:133-137.
Dieterle C, Brendel MD, Seissler J, Eckhard M, Bretzel RG, Landgraf. (2006) Therapy of diabetes mellitus: Pancreas transplantation, islet transplantation, stem cell and gene therapy. Internist 47:489-501.
Kaiser C, Gotzberger M, Landauer N, Dieterle C, Heldwein W, Schiemann U. (2007) Age dependency of intrarenal resistance index (RI) in healthy adults and patients with fatty liver disease. Eur J Med Res12:191-195.
Dieterle CD, Arbogast H, Illner WD, Schmauss S, Landgraf R. (2007) Metabolic follow-up after long-term pancreas graft survival. Eur J Endocrinol 156:603-610.
Zimmermann US, Buchmann A, Steffin B, Dieterle C, Uhr M.(2007) Alcohol administration acutely inhibits ghrelin secretion in an experiment involving psychosocial stress. Addict Biol 12:17-21.
Dieterle CD, Schmauss S, Arbogast H, Domsch C, Huber RM, Landgraf R.(2007) Pulmonary function in patients with type 1 diabetes before and after simultaneous pancreas and kidney transplantation. Transplantation 83:566-569.
Diabetes Zentrum: Most Cited Papers
Liste der 10 meist zitierten Originalpublikationen (Erst- oder Senior-Autoren) von Mitgliedern des Diabetes-Zentrums (Quelle, Web of Science 1/2007)
1. Seissler J, Morgenthaler NG, Achenbach P, et al. (1996) Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM. Diabetologia 39:1351-1356.
2. Seissler J, de Sonnaville JJJ, Morgenthaler NG, et al. (1998) Immunological heterogeneity in Type I diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease Diabetologia 41:891-897.
3. Seissler J, Amann J, Mauch L et al. (1993) Prevalence of autoantibodies to the 65-KD and 67-KD isoforms of glutamic acid decarboxylase in insulin-dependent diabetes mellitus. J Clin Invest 92:1394-1399.
4. Seissler J, Boms S, Wohlrab U, et al. (1999) Antibodies to human recombinant tissue transglutaminase measured by radioligand assay: Evidence for high diagnostic sensitivity for celiac disease. Horm Met Res 31:375-379.
5. Schott M, Seissler J, Lettmann M, et al. (2001) Immunotherapy for medullary thyroid carcinoma by dendritic cell vaccination. J Clin Endorin Metab 86:4965-4969.
6. Lohmann T, Kellner K, Verlohren HJ, et al. (2001) Titre and combination of ICA and autoantibodies to glutamic acid decarboxylase discriminate two clinically distinct types of latent autoimmune diabetes in adults (LADA). Diabetologia 44:1005-1010.
7. Seissler J, Hering B, Richter W et al. (1992) Antibodies to the Mr 64.000 (64K) protein in islet cell antibody positive individuals indicate high risk for impaired beta-cell function. Diabetologie 35:550-554.
8. Schott M, Feldkamp J, Bathan C, et al. (2000) Detecting TSH-Receptor antibodies with the recombinant TBII assay: Technical and clinical evaluation. Horm Met Res 32:429-435.
9. Seissler J, Wohlrab U, Wuensche C, et al. (2001) Autoantibodies from patients with coeliac disease recognize distinct functional domains of the autoantigen tissue transglutaminase. Clin Exp Immunol 125:216-221.
10. Schattenberg D, Schott M, Reindl G, et al. (2000) Response of human monocyte-derived dendritic cells to immunostimulatory DNA. Europ J Immunol 30:2824-2831.